NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
217.90
Change Change %
2.65 1.23%

Updated:03 Sep, 2015, 15:56 PM IST

BSE
217.75
Change Change %
2.00 0.93%

Updated:03 Sep, 2015, 15:57 PM IST

Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

216.20 221.55

52 Wk Range

157.00 338.50
Period:

Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)

Day's Range

216.70222.00

52 Wk Range

157.15 338.50

Compare Price performance of vs. Peer Companies

From sector

Compare with Peers on Key Fundamentals and Financials

Color code for Price performance of and Peer companies

  • 5% and above
  • 2% to 5%
  • 0.5% to 2%
  • -0.5% to 0.5%
  • -2% to -0.5%
  • -5% to -2%
  • -5% and below

Suven Life Sciences's Key Fundamentals

Parameter Values
Market Cap (in ₹ Cr.) 2,773.47
Earning Per Share (EPS TTM) (₹) 7.86
Price To Earnings (P/E) Ratio 27.72
Book Value Per Share (₹) 43.56
Price To Books (P/B) Ratio 5.00
EBIT Margin (%) 29.96
PAT Margin (%) 20.85
ROCE (%) 30.70
PAT Growth (%) -24.56
Total Debt to Equity (D/E) Ratio 0.20

More from Key Fundamentals »

Suven Life Sciences's Financial Summary

Parameter MAR'15
(₹ Cr.)
MAR'14
(₹ Cr.)
YoY
%Change
Balance Sheet:
Share Capital 12.73 11.68 8.95%
Total Non-Current Liabilities 86.43 67.12 28.78%
Total Current Liabilities 127.39 155.06 -17.85%
Total Liabilities 773.13 486.63 58.88%
Total Non-Current Assets 291.31 206.06 41.37%
Currents Investments 0.04 0.04 0.00%
Cash and Bank 279.69 68.03 311.14%
Total Current Assets Excluding Current Investments 476.94 280.53 70.02%
Total Assets 773.13 486.63 58.88%
Profit and Loss:
Gross Sales 521.60 510.59 2.16%
Net Sales 520.86 510.31 2.07%
PBIDT (Excl OI) 159.46 219.06 -27.21%
PAT 108.75 144.16 -24.56%

More from Financial Summary �

Suven Life Sciences's Shareholding Pattern

Suven Life Sciences held by Mutual Fund Schemes

Scheme Holding(%)
No Records Found!

Post your comments about Suven Life Sciences